I. Devesa

发表

Therapeutic administration of 3,4,5-trimethoxy-4'-fluorochalcone, a selective inhibitor of iNOS expression, attenuates the development of adjuvant-induced arthritis in rats

M. Payá, J. Rojas, I. Devesa, 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

Influence of heme oxygenase 1 modulation on the progression of murine collagen-induced arthritis.

L. Joosten, M. Alcaraz, W. B. van den Berg, 2005, Arthritis and rheumatism.

Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages.

L. Joosten, M. Netea, C. Dinarello, 2009, Blood.

Neurotrophins, endocannabinoids and thermo‐transient receptor potential: a threesome in pain signalling

A. Ferrer-Montiel, I. Devesa, 2014, The European journal of neuroscience.

Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice.

L. Joosten, F. D. Di Padova, W. B. van den Berg, 2008, Arthritis and rheumatism.

Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis.

L. Joosten, W. B. van den Berg, J. Roth, 2011, Arthritis and rheumatism.

Treatment with a CO-releasing molecule (CORM-3) reduces joint inflammation and erosion in murine collagen-induced arthritis

L. Joosten, M. Alcaraz, W. B. van den Berg, 2007, Annals of the rheumatic diseases.

The CO-releasing molecule CORM-3 protects against articular degradation in the K/BxN serum transfer arthritis model.

M. Alcaraz, W. B. van den Berg, R. Motterlini, 2010, European journal of pharmacology.

A new pyrazolo pyrimidine derivative inhibitor of cyclooxygenase-2 with anti-angiogenic activity.

M. Alcaraz, R. Riguera, M. Ferrándiz, 2004, European journal of pharmacology.

Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis.

L. Joosten, S. Akira, W. B. van den Berg, 2008, The Journal of clinical investigation.

Potential role of heme oxygenase-1 in the progression of rat adjuvant arthritis

M. Alcaraz, M. Ferrándiz, I. Guillén, 2005, Laboratory Investigation.

Bypassing pathogen-induced inflammasome activation for the regulation of interleukin-1beta production by the fungal pathogen Candida albicans.

L. Joosten, M. Netea, N. Gow, 2009, The Journal of infectious diseases.

processing and release of IL-1{beta} in monocytes and macrophages Differential requirement for the activation of the inflammasome for

M. Netea, J. Meer, M. Nold, 2009 .

processing and release of IL-1 Differential requirement for the activation of the inflammasome for

C., L. Joosten, M. Netea, 2009 .

Calcium Entry Through Thermosensory Channels.

A. Ferrer-Montiel, I. Devesa, F. J. Taberner, 2016, Advances in experimental medicine and biology.

Trafficking of ThermoTRP Channels

A. Ferrer-Montiel, I. Devesa, Clotilde Ferrándiz-Huertas, 2014, Membranes.

A novel agonist of the type 1 lysophosphatidic acid receptor (LPA1), UCM-05194, shows efficacy in neuropathic pain amelioration.

J. Chun, A. Ferrer-Montiel, R. Rivera, 2019, Journal of medicinal chemistry.

Role of the transient receptor potential vanilloid 1 in inflammation and sepsis

J. González-Ros, G. Fernández-Ballester, A. Fernández-Carvajal, 2011, Journal of inflammation research.

6-Dimethylamino 1H-pyrazolo[3,4-d]pyrimidine derivatives as new inhibitors of inflammatory mediators in intact cells.

M. Alcaraz, C. Peinador, R. Riguera, 2003, Bioorganic & medicinal chemistry.

New Strategies to Develop Novel Pain Therapies: Addressing Thermoreceptors from Different Points of View

J. González-Ros, G. Fernández-Ballester, A. Fernández-Carvajal, 2011, Pharmaceuticals.

Bradykinin Induces TRPV1 Exocytotic Recruitment in Peptidergic Nociceptors

J. Changeux, A. Ferrer-Montiel, I. Devesa, 2016, Front. Pharmacol..

Inducers of heme oxygenase-1.

M. Ferrándiz, I. Devesa, 2008, Current pharmaceutical design.

DD04107-Derived neuronal exocytosis inhibitor peptides: Evidences for synaptotagmin-1 as a putative target.

M. Martín-Martínez, O. Abián, A. Velázquez‐Campoy, 2021, Bioorganic chemistry.

αCGRP is essential for algesic exocytotic mobilization of TRPV1 channels in peptidergic nociceptors

J. Changeux, R. Luján, A. Ferrer-Montiel, 2014, Proceedings of the National Academy of Sciences.

A capsaicinoid-based soft drug, AG1529, for attenuating TRPV1-mediated histaminergic and inflammatory sensory neuron excitability

A. Fernández-Carvajal, A. Ferrer-Montiel, T. Pirali, 2021, Scientific reports.

Effects of heme oxygenase-1 inducers on established rat adjuvant arthritis.

M. Alcaraz, J. Busserolles, M. Ferrándiz, 2005, Cellular and molecular biology.

Benzydamine inhibits neuronal excitability induced by inflammatory mediators to relieve pain

A. Ferrer-Montiel, G. Mangano, L. Polenzani, 2022, Biophysical Journal.

Design and validation of neuronal exocytosis blocking peptides as potential novel antiperspirants

G. Fernández-Ballester, A. Fernández-Carvajal, A. Ferrer-Montiel, 2023, Experimental dermatology.

Targeting protein–protein interactions to rescue Δf508-cftr: a novel corrector approach to treat cystic fibrosis

Antonio Ferrer-Montiel, G. Fernández-Ballester, A. Ferrer-Montiel, 2013, EMBO molecular medicine.

Benzydamine plays a role in limiting inflammatory pain induced by neuronal sensitization

G. Mangano, Magdalena Nikolaeva-Koleva, I. Devesa, 2023, Molecular pain.

Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders.

A. Fernández-Carvajal, A. Ferrer-Montiel, G. Sorba, 2018, Journal of medicinal chemistry.